Utility of a novel lipoarabinomannan assay for the diagnosis of tuberculous meningitis in a resource-poor high-HIV prevalence settingAbility of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypesDuffy-null-associated low neutrophil counts influence HIV-1 susceptibility in high-risk South African black womenLack of Duffy antigen receptor for chemokines: no influence on HIV disease progression in an African treatment-naive populationPrevalence and Characteristics of Hepatitis B Virus (HBV) Coinfection among HIV-Positive Women in South Africa and BotswanaClinical, Virologic, Immunologic Outcomes and Emerging HIV Drug Resistance Patterns in Children and Adolescents in Public ART Care in ZimbabweSelection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South AfricaInfectious simian/human immunodeficiency virus with human immunodeficiency virus type 1 subtype C from an African isolate: rhesus macaque model.HIV-1 subtype C in vitro growth and coreceptor utilization.Replicative capacity of human immunodeficiency virus type 1 transmitted from mother to child is associated with pediatric disease progression rateHIV subtype influences HLA-B*07:02-associated HIV disease outcome.Relationship of Human Immunodeficiency Virus Viral Load in Cerebrospinal Fluid and Plasma in Patients Co-infected With Cryptococcal Meningitis.CD8 T cell response and evolutionary pressure to HIV-1 cryptic epitopes derived from antisense transcriptionMolecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from BotswanaPARV4 prevalence, phylogeny, immunology and coinfection with HIV, HBV and HCV in a multicentre African cohort.Temporal reduction of HIV type 1 viral load in breast milk by single-dose nevirapine during prevention of MTCTAmino-acid co-variation in HIV-1 Gag subtype C: HLA-mediated selection pressure and compensatory dynamics.Effect of female genital schistosomiasis and anti-schistosomal treatment on monocytes, CD4+ T-cells and CCR5 expression in the female genital tract.Compartmentalization of innate immune responses in the central nervous system during cryptococcal meningitis/HIV coinfectionIdentification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine designConstruction and analysis of an infectious human Immunodeficiency virus type 1 subtype C molecular clone.Genetic characteristics, coreceptor usage potential and evolution of Nigerian HIV-1 subtype G and CRF02_AG isolates.Exposure to HIV-1-encoded Toll-like receptor 8 ligands enhances monocyte response to microbial encoded Toll-like receptor 2/4 ligands.A molecular assay for sensitive detection of pathogen-specific T-cellsThe fitness landscape of HIV-1 gag: advanced modeling approaches and validation of model predictions by in vitro testing.Major histocompatibility complex class II (HLA-DRB and -DQB) allele frequencies in Botswana: association with human immunodeficiency virus type 1 infection.Managing the demand for global health education.Evaluation of the NucliSens EasyQ v2.0 assay in comparison with the Roche Amplicor v1.5 and the Roche CAP/CTM HIV-1 Test v2.0 in quantification of C-clade HIV-1 in plasmaCerebrospinal T-cell responses aid in the diagnosis of tuberculous meningitis in a human immunodeficiency virus- and tuberculosis-endemic populationAdditive contribution of HLA class I alleles in the immune control of HIV-1 infection.Gag-protease-mediated replication capacity in HIV-1 subtype C chronic infection: associations with HLA type and clinical parametersHLA-Cw*03-restricted CD8+ T-cell responses targeting the HIV-1 gag major homology region drive virus immune escape and fitness constraints compensated for by intracodon variationImmunodominant HIV-1-specific HLA-B- and HLA-C-restricted CD8+ T cells do not differ in polyfunctionality.Comparison of amplicor and GeneXpert MTB/RIF tests for diagnosis of tuberculous meningitis.Prospective monitoring reveals dynamic levels of T cell immunity to Mycobacterium tuberculosis in HIV infected individualsCharacterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infectionTranslating HIV sequences into quantitative fitness landscapes predicts viral vulnerabilities for rational immunogen design.Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C.HIV-1 subtype C envelope characteristics associated with divergent rates of chronic disease progressionHuman immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?
P50
Q21231998-61843D63-08A0-4EF7-A62E-8B407760146AQ21245213-7BE27DF7-A6FF-4671-A67C-3B68786B3514Q24613572-2826D2BF-A41A-4416-BC2F-56A461F00481Q24648631-4D212022-B36D-4B87-A715-EC5493D1238BQ28546809-745301AC-15F8-47D3-BBF4-4995F0C8B3AAQ28551494-32F4F924-4CBA-4D58-A96F-7D6EE7131FF4Q28607344-4EBA1870-8A47-4F1D-8412-6BB51605B556Q30329167-408B5E80-3CFE-4CCF-A9EE-4856DFB6EB91Q30352511-84489877-4BCD-470D-B35C-1D4982E41510Q33558599-F379305C-A6FB-4D18-8F75-CA9EE256059BQ33566546-2F0F07AE-D2E4-4D1D-B52F-DD00E7D50BECQ33609454-37E53297-7380-4319-A39C-471027934044Q33615194-CD183A3A-4067-42A5-B94A-C7CDEFA36609Q33648343-B8031182-975A-42A3-817A-B3B10A075A93Q33652856-44CE5A63-BDDB-4EBF-B5D6-BEDF0F3AF78AQ33686897-3625CE54-9B5B-4556-9E5E-88A6664CFE1CQ33687232-DD07D649-E5A6-4644-8685-3674671A6EAEQ33711969-0F3A3FBB-450B-4B55-81C1-2D92ABBCA758Q33831703-F760EFC3-5882-4C70-9C48-76DC1B28400CQ33845527-1B7FE991-7C34-4E36-9D6C-988883754FB9Q33851598-3F858A07-3B77-424F-93A8-83AF9CBBF70EQ33851789-56E7D707-4122-4FF0-94E9-6298593A86B7Q33987810-C23E0C7A-8189-42A0-B5A9-FFC0B76DF8ADQ33996692-85613F85-D5EE-4718-B9BB-6F526FA5D545Q34015177-97C7B392-CEEC-4515-B40B-10C7D4AAC089Q34045503-39A5C7F4-FC6A-4A7E-8114-9CFF843A655DQ34075378-712B1362-4A1E-4900-96AD-1297F4B49EBAQ34089637-540D6E5D-0792-424C-B050-426F9475526FQ34118528-C4895927-8427-49ED-841E-D69B847197DFQ34120809-8E6F05A8-09A5-4198-BE2C-E4D96E6754F2Q34178349-9103B840-C4B4-4381-AF83-A7DBA7972587Q34190667-438DA369-4BFF-48F2-A021-5992D05CCFDCQ34195857-D220649F-8268-43CB-9407-B6B588C91CD4Q34298219-C79D0C38-F61E-4B80-810A-1849AF96FEF1Q34299551-5921BE0A-B138-4A99-B8C3-7221A12F2C4FQ34300812-86939153-D6CC-4353-B9AB-BB6242DD7138Q34334803-A2C6E124-A08A-48CC-ABDA-0145EE342DDFQ34348269-4783A03B-E90A-4FD9-8BC8-5F470E87988EQ34350944-716FB231-2314-4D12-ADD0-F4E816C0BD26Q34364357-5385B470-8CE1-422F-9249-3B2D4D75C964
P50
description
Kenyan virologist
@en
virologo keniota
@it
viroloog uit Kenia
@nl
virólogo keniata
@es
virólogu kenianu
@ast
عالم فيروسات كيني
@ar
name
Thumbi Ndung'u
@ast
Thumbi Ndung'u
@da
Thumbi Ndung'u
@de
Thumbi Ndung'u
@en
Thumbi Ndung'u
@es
Thumbi Ndung'u
@fr
Thumbi Ndung'u
@ga
Thumbi Ndung'u
@it
Thumbi Ndung'u
@nb
Thumbi Ndung'u
@nl
type
label
Thumbi Ndung'u
@ast
Thumbi Ndung'u
@da
Thumbi Ndung'u
@de
Thumbi Ndung'u
@en
Thumbi Ndung'u
@es
Thumbi Ndung'u
@fr
Thumbi Ndung'u
@ga
Thumbi Ndung'u
@it
Thumbi Ndung'u
@nb
Thumbi Ndung'u
@nl
altLabel
Ndung'u T
@en
Ndung'u T.
@en
Ndung'u
@en
T Ndung'u
@en
T. Ndung'u
@en
prefLabel
Thumbi Ndung'u
@ast
Thumbi Ndung'u
@da
Thumbi Ndung'u
@de
Thumbi Ndung'u
@en
Thumbi Ndung'u
@es
Thumbi Ndung'u
@fr
Thumbi Ndung'u
@ga
Thumbi Ndung'u
@it
Thumbi Ndung'u
@nb
Thumbi Ndung'u
@nl
P214
P101
P106
P19
P21
P214
P27
P31
P496
0000-0003-2962-3992
P569
1969-01-01T00:00:00Z
P7859
viaf-306421897